BiOligo leads the way with cutting-edge technologies, including our flagship Super-Quenched Probes, which provide exceptional signal clarity and assay sensitivity. In 2024, we expanded our diagnostics portfolio with the launch of ICE Probes, a next-generation solution designed for melting curve analysis that outperforms traditional TaqMan probes in precision and specificity.
For next-generation sequencing, our NGS Library Prep kits are recognized by leading genomic institutions as established workflows—trusted by labs worldwide for reliable data generation. Additionally, our ready-to-use Premix Kits simplify complex workflows, offering consistency, convenience, and robust performance across a wide range of applications.
our oligo and reagent solutions are also optimized for RNA interference (RNAi), supporting researchers who rely on high-fidelity RNA synthesis, siRNA duplexes, and critical delivery components for gene regulation and functional genomic studies.
Today, thousands of IVD and CGT (Cell & Gene Therapy) innovators worldwide rely on BiOligo for high-quality, consistent, and reliable raw materials. We are actively seeking new partnerships to accelerate progress in genomic diagnostics and therapeutic development, shaping a healthier future together.